A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
about
Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trialExploring a structural protein-drug interactome for new therapeutics in lung cancerGenDrux: a biomedical literature search system to identify gene expression-based drug sensitivity in breast cancer.Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.Beyond standard adjuvant therapy for colon cancer: role of nonstandard interventionsImpact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.IκBKβ and NFκB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry.Analysis of the Functional Polymorphism in the Cytochrome P450 CYP2C8 Gene rs11572080 with Regard to Colorectal Cancer Risk.Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer.Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.Will an aspirin a day keep the colorectal cancer away?Response
P2860
Q33503521-A40BA325-057F-485D-9E15-0AE30116F53DQ33593907-A42BF6B5-B4E6-40B0-9CE4-6C243AE7AAD0Q33890542-C5CB0D03-FEDC-44DB-AA8E-58C4C10F52C2Q35078297-1C6F7E8F-345E-48AD-AD2E-4F80E5C84B19Q35147929-AA452D03-A513-41C9-97C6-52242EA1D234Q35619102-21C6B57D-DBE5-4C1D-8E35-0F7A1735A042Q36487403-16BDDFE3-8134-4698-8E07-740CA6E9C52CQ36499740-5011A395-8C7B-43F8-B176-E28A1F7F153AQ36611264-F21158A2-773D-4014-BC65-75247FB391F2Q36974684-375EE059-E00D-4041-AC68-041DE18A8860Q37554165-E28EB313-222A-4E30-9DFC-BDCDA7B6BC0FQ37930487-A187417F-EFA2-439B-AF7F-7651444DD712Q38357424-CC045B22-1478-4186-875F-265F9688AC7BQ41404998-68451A9E-32D3-4698-8498-3B56B91A6040Q57258032-06B3A434-DFCF-4539-B595-BC6BBC4AA731Q58139661-D617796E-7C99-4B68-99DC-FC82AFE24B1F
P2860
A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of gene-drug interact ...... eventing colorectal neoplasia.
@en
A review of gene-drug interact ...... eventing colorectal neoplasia.
@nl
type
label
A review of gene-drug interact ...... eventing colorectal neoplasia.
@en
A review of gene-drug interact ...... eventing colorectal neoplasia.
@nl
prefLabel
A review of gene-drug interact ...... eventing colorectal neoplasia.
@en
A review of gene-drug interact ...... eventing colorectal neoplasia.
@nl
P2093
P2860
P356
P1476
A review of gene-drug interact ...... eventing colorectal neoplasia.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.TPJ.6500487
P577
2008-01-15T00:00:00Z